Premji Invest backs Maharashtra-based hospital chain NewEra Hospitals

Premji Invest, the investment firm of billionaire Azim Premji, announced on Thursday that it has invested an undisclosed amount in NewEra Hospitals to scale the multi-specialty hospital chain in Maharashtra.

Premji Invest’s capital will be used to open three new hospitals in Nagpur and increase capacity from 350 to 800 beds. NewEra Hospitals currently has two hospitals in Nagpur and one hospital in Navi Mumbai. The aim is to deepen access to quaternary care across the region.

“Structural gaps in India’s healthcare delivery system remain,” Prakash Chellam, partner and head of healthcare and life sciences at Premji Invest, said in a statement. According to Chellam, Nagpur needs better medical facilities and more hospital beds. By supporting NewEra, they are investing in a team of three forward-thinking doctors who are committed to improving the quality of healthcare and expanding the solid clinical foundation they have already established in Nagpur and Navi Mumbai.

Founded in 2016 by experienced doctors Dr Anand Sancheti, Dr Nilesh Agrawal and Dr Nidheesh Mishra, NewEra has a strong foundation. Clinical reliability in complex specialties such as neurosciences, transplantation and cardiology.

With this expansion The hospital chain aims to position itself as the leading quaternary care provider in Nagpur and one of the key regional hospital platforms in Maharashtra.

“We have always believed that quality quadruple care should not be a privilege limited to patients in major cities. This investment provides us with the infrastructural runway to deliver on this promise at scale,” said co-founder Dr Anand Sancheti.

Premji Invest had previously supported Manipal Hospitals, Medplus and medical supplies manufacturer TI Medical in India, as well as several biotech and healthcare firms in the US, including Bicara Therapeutics, Moderna and DevotedHealth.

India’s health services, especially World War II. and III. Investments targeting tier-one markets are increasing. According to EY-Parthenon, India’s Q2FY26 health report published in January 2026, in this quarter alone ₹Announced transaction worth Rs 10,000 crore in hospitals, diagnostics and specialty care, including acquisitions, minority investments and cross-border acquisitions.